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ABSTRACT 
Preharvest intervention strategies to reduce Escherichia coli 0157:H7 in cattle have been sought as a means to reduce 
human foodborne illness. A blinded clinical trial was conducted to test the effect of a vaccine product on the probability that 
feedlot steers, under conditions of natural exposure, shed E. coli 0157:H7 in feces, are colonized by this organism in the 
terminal rectum, or develop a humoral response to the respective antigens. Steers (n = 288) were assigned randomly to 36 
pens (eight head per pen), and pens were randomized to vaccination treatment in a balanced fashion within six dietary 
treatments of an unrelated nutrition study. Treatments included vaccination or placebo (three doses at 3-week intervals). Fecal 
samples for culture (n = 1,410) were collected from the rectum of each steer on pretreatment day 0 and posttreatment days 
14, 28,42, and 56. Terminal rectum mucosal (TRM) cells were aseptically collected for culture at harvest (day 57 posttreatment) 
by scraping the mucosa 3.0 to 5.5 cm proximal to the rectoanal junction. E. coli 0157:H7 was isolated and identified with 
selective enrichment, immunomagnetic separation, and PCR confirmation. Vaccinated cattle were 98.3% less likely to be 
colonized by E. coli 0157:H7 in TRM cells (odds ratio = 0.014, P < 0.0001). Diet was also associated with the probability 
of cattle being colonized (P = 0.04). Vaccinated cattle demonstrated significant humoral responses to Tir and 0157 lipopoly- 
saccharide. These results provide evidence that this vaccine product reduces E. coli 0157:H7 colonization of the terminal 
rectum of feedlot beef cattle under conditions of natural exposure, a first step in its evaluation as an effective intervention for 
food and environmental safety. 
Escherichia coli 0157:H7 is an important foodborne, 
zoonotic pathogen of humans (1, 3, 60). This organism is 
the prototype of the enterohemorrhagic E. coli class, or- 
ganisms that characteristically cause hemorrhagic colitis 
and hemolytic uremic syndrome in humans (32). Entero- 
hemorrhagic E. coli strains produce a type of Shiga toxin 
(Stx), which has a principal function in the causation of 
vascular damage (60). In addition, these strains produce at- 
taching-effacing lesions in the intestines, which contribute 
to the pathogenesis (26, 39). Stx is produced not only by 
serotype 0157:H7, but also by many other serotypes of E. 
coli that are consequently referred to as Shiga toxin-pro- 
ducing E. coli (31, 48). Nearly 500 0 serotypes of Shiga 
toxin-producing E. coli have been isolated from humans 
with disease; however, <10 cause the majority of cases 
(21). Hence, based on the importance of Stx as a virulence 
factor (31, 60), Shiga toxin-producing E. coli is considered 
a potential pathogen for humans, although it is likely that 
not all strains have the ability to cause disease, because the 
pathogenesis is multifactorial and involves multiple viru- 
lence factors (21, 31, 48). 
* Author for correspondence. Tel: 402-472-2362; Fax: 402-472-9690; 
E-mail: dsmith8 @unl.edu. 
t Contribution from the University of Nebraska Agricultural Research Di- 
vision, Lincoln, journal series 14698. 
In the United States, ground beef is the most common 
vehicle associated with foodborne outbreaks of E. coli 
0157:H7 (2, 7). Cattle are an asymptomatic reservoir of 
this microorganism and shed it in the feces (38, 55, 59). 
Fecal material is an important source of infection for hu- 
mans, who most often acquire the organism in contaminat- 
ed food and water or by direct contact with carrier animals 
(1, 8, 52, 55). The proportion of cattle carrying E. coli 
0157:H7 in the feces or on hides is correlated with post- 
harvest rates of carcass contamination with the same or- 
ganism (16). Preharvest strategies to prevent foodborne ill- 
ness in humans, e.g., reduction of the prevalence of cattle 
shedding E. coli 0157:H7 in their feces, have been pro- 
posed early on to prevent foodborne illness (10, 22), and 
this has become a major focus of research groups around 
the world (6, 35, 59). 
Bacterial virulence mechanisms important in intestinal 
colonization are a logical target for intervention strategies. 
The outer membrane protein intimin (Eae) and the type 111 
secreted proteins, including but not limited to the translo- 
cated-intimin receptor (Tir) and E. coli-secreted proteins 
([Esp] A and B), are bacterial proteins that mediate the 
formation of attaching-effacing lesions (23). These proteins 
are encoded on a pathogenicity island called the locus of 
enterocyte effacement (LEE) (1 7). After E. coli 0 157:H7 
contacts a mucosal epithelial cell in the intestine, it delivers 
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Tir, EspB, and other type I11 secreted proteins into the cell 
through a transiently produced translocation tube (44), 
which structurally consists of an assembly of EspA subunits 
(1 7). A series of cytoskeletal alterations resulting in efface- 
ment of the rnicrovilli and pedestal formation at the site of 
bacterial attachment ensues (53). Subsequently, intimin is 
bound to Tir, which is integrated into the host cell mem- 
brane, and this effects intimate attachment (13). 
The relationship and relevance of attaching-effacing le- 
sions to intestinal colonization have been demonstrated by 
mutagenesis studies. Inactivation of the gene encoding in- 
timin (eae) in E. coli 0157:H7 has significantly reduced 
enteritis and bacterial fecal shedding in experimentally in- 
fected neonatal calves ( I  I )  and colonization and fecal shed- 
ding in yearling cattle (9). Similarly, experimental chal- 
lenge of calves with an E. coli 0157:H7 strain containing 
a deletion in the operon (LEE4) that encodes the type I11 
secreted proteins resulted in reduced colonization and fecal 
shedding (42). 
Human patients with E. coli 0 157:H7-associated dis- 
ease (e.g., hemolytic uremic syndrome) were found to de- 
velop a robust serum antibody response to Tir (34, 65), and 
based on this observation, the hypothesis was raised that 
type I11 secreted proteins would make a suitable vaccine 
target for this pathogen in humans and cattle (34). Subse- 
quent studies demonstrated that a vaccine prepared from 
culture supernatant materials enriched with type I11 secreted 
proteins has significant potential as a preharvest interven- 
tion strategy for E. coli 0157:H7 (50). However, to our 
knowledge, the effect of this vaccine on colonization of the 
MATERIALS AND METHODS 
Source of cattle. Two hundred eighty-eight crossbred steers 
were obtained in the fall of 2003 and grown in a winter-grazing 
system until they were placed in their respective treatment pens 
on day 1 of the trial (19 May 2004). Prior to day 1 of the trial, 
steers were limit fed a 50% alfalfa hay:50% wet corn gluten feed 
diet on a dry matter (DM) basis at 2% body weight (BW) for 5 
consecutive days to reduce variation in initial weight due to gut 
fill. Initial BWs (352 2 11 [SD] kg) were calculated as the av- 
erage of weights taken the last 2 days of the 5-day limit-fed pe- 
riod. 
Study design. Upon completion of the first weigh day, steers 
were stratified by BW so that the heaviest 36 cattle could be 
assigned within their weight strata to 36 pens with a random num- 
ber generator. This randomization process was repeated seven 
times so that each pen housed a total of eight steers with initial 
BW distributed evenly among the 36 pens. 
Six pens were assigned to each of six dietary treatments with 
a random number generator in a balanced fashion. Six levels of 
dietary treatments evaluated the level of wet distillers' grains plus 
solubles (DG) on cattle performance as follows: (i) 0% DG 
(OODG), (ii) 10% DG (IODG), (iii) 20% DG (20DG), (iv) 30% 
DG (30DG), (v) 40% DG (40DG), and (vi) 50% DG (50DG), all 
included in the rations as a percentage of DM. Alfalfa hay was 
included in all diets at 5.0% of DM, and high-moisture corn and 
dry-rolled corn were fed at a 1: 1 ratio (DM basis). DG replaced 
corn in each treatment diet. 
Vaccination treatments were assigned randomly within die- 
tary treatment in a balanced fashion, so that within each group of 
six pens of a dietary treatment, three were randomly assigned to 
receive one of two vaccine treatments (total of I8 pens per vac- 
cination treatment). The vaccine (2 ml Der dose: Bioniche Life 
terminal rectum has not previously been tested. Sciences, Belleville, Ontario, Canada) was administered subcuta- 
The reduction in colonization and fecal shedding in neously in the neck with an 1 %gauge, 1.6-cm needle. The vaccine 
experimentally infected calves that result from the deletion contained secreted proteins prepared from E. coli 0157:H7 as pre- 
of the LEE4 ODeron in the E. coli 0157:H7 strain was con- viously described (34, 50) and was formulated with the adjuvant 
cluded to provide a proof of concept for the utilization of 
type 111 secreted proteins as a vaccine strategy (42). How- 
ever, some studies have not found vaccination to be effi- 
cacious. One of these utilized type 111 secreted proteins as 
the vaccine antigen, although they were formalin treated, 
which may have altered the immunogenicity of the vaccine 
(63). A recent study involved vaccinating young calves < 1 
month old by the intramuscular route with subunit intim- 
in28o-, Efa- 1 ', and enterohemorrhagic E. coli bacterin, sin- 
gularly or in combination, and then boosting by intranasal 
exposure with the same antigens with cholera toxin B sub- 
unit as an adjuvant (62). Although the calves developed 
humoral antibodies and some developed salivary immuno- 
globulin A (IgA) antibodies to the homologous antigen, 
they were not protected against intestinal colonization by 
E. coli 0157:H7 following experimental challenge (62). 
The objectives of this clinical trial were to test, under 
conditions of natural exposure, the effect of a vaccine con- 
taining E. coli type I11 secreted proteins on (i) the proba- 
bility that feedlot steers shed E. coli 0157:H7 in the feces, 
(ii) the probability that feedlot steers are colonized by this 
organism in the terminal rectum, (iii) the growth perfor- 
mance of cattle, and (iv) the humoral immune responses to 
the respective antigens. 
Emulsigen D (MVP Laboratories, Omaha, Nebr.) such that the 
protein concentration was 66.1 J . L ~  per dose. Vaccination treat- 
ments were coded A (vaccination) and B (placebo), so that all 
feedlot and laboratory personnel were blinded to treatments until 
after completion of the study. All steers received three doses of 
the vaccine or placebo (adjuvant only) at 21-day intervals on days 
28, 49, and 70 of the 126-day feeding period. The study timeline 
is summarized in Table 1. 
Management, sampling procedures, and carcass data col- 
lection. Feedlot personnel visually evaluated feedbunks each 
morning to assign a daily allotment of feed to each pen of cattle. 
Additionally, experienced animal health personnel visually ap- 
praised cattle three times each week to evaluate health status. 
Feces were collected per rectum from each steer on day 28 
of the feeding period and every 14 days following completion of 
the three-dose regimen, resulting in one pretreatment sample (day 
28 of the feeding period) and four test-period samplings at days 
84, 98, 112, and 126 of the feeding period (14, 28, 42, and 56 
days following completion of the three-dose regimen). Individual 
BWs were collected concurrently with fecal sampling. 
Serum samples were collected from cattle on days 28, 84, 
and 126 of the feeding period (pretreatment and 14 and 56 days 
following completion of the three-dose regimen). Enzyme-linked 
immunosorbent assay (ELISA) titers were determined, as de- 
scribed below, from two systematic-randomly selected steers with- 
in each pen (72 cattle in total). The systematic-random selection 
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TABLE 1. Study timetable 
Posttreat- 
Date Feedyard Treatment ment Samples 
(2004) days days days Description collected 
19 May 
15 Jun. 
6 Jul. 
27 Jul. 
10 Aug. 
24 Aug. 
7 Sep. 
21 Sep. 
22 Sep. 
23 Sep. 
Placed into 
feedy ard 
First treat- 
ment dose 
Second treat- 
ment dose 
Third treat- 
ment dose 
Test period 1 
Test period 2 
Test period 3 
Test period 4 
Harvest 
Completion 
of harvest 
Blood, feces 
Blood, feces 
Feces 
Feces 
Blood, feces 
Terminal 
rectum 
mucosa 
Terminal 
rectum 
mucosa 
process was to randomly assign the eight steers from each pen a 
value of one to eight and then select serum from animals with the 
same two randomly selected values (e.g., steers 3 and 6 from each 
pen). 
Samples of terminal rectum mucosal (TRM) cells were col- 
lected at the abattoir. Following evisceration of the animal, an 
abattoir worker removed the terminal 20 to 30 cm of the large 
intestine and placed it into a plastic bag, along with an identifi- 
cation tag. Minutes later, at a separate location in the abattoir, 
laboratory workers made an incision lengthwise along the excised 
large intestinal segment to expose the mucosal surface and re- 
moved the contents with a sterile wooden tongue depressor. Fol- 
lowing removal of all visible material from the lumen and mu- 
cosal surface, a 2.5-cm-wide circumferential band of TRM cells, 
extending from 3.0 to 5.5 cm proximal to the rectoanal junction, 
was obtained by scraping with a sterile glass microscope slide 
(Fig. 1). Approximately 1.5 g of TRM cells was harvested from 
each animal and placed in 15 ml of chilled, modified Cary-Blair 
transport media (ParaPak C & S, Meridian Bioscience, Inc., Cin- 
cinnati, Ohio). Transport media vials were submitted to the lab- 
oratory on ice and refrigerated (4°C) until TRM cells were cul- 
tured. TRM cells were cultured within 24 h after collection from 
the animal. Sample collectors and laboratory personnel were 
blinded to the treatment of the animals. 
Feedlot performance outcomes of average daily gain, daily 
DM intake, and feed efficiency were calculated from individual 
(average daily gain) and pen-level measures. Carcass characteristic 
outcomes were obtained from individual cattle at harvest and in- 
cluded the hot carcass weight, 12th-rib fat thickness, U.S. De- 
partment of Agriculture (USDA) marbling score, and USDA yield 
grade. Carcass weights were recorded immediately prior to wash- 
ing and placement of the carcass in the cooler. After the carcass 
was chilled for 24 h, fat thickness, marbling score, and yield grade 
were recorded. Marbling score is indicative of intramuscular fat 
at the 12th rib and recorded on a scale of 300 = slight marbling 
(USDA select quality grade) and 400 = small marbling (USDA 
low choice quality grade). Yield grade measures are based on a 
scale of 1 to 5. Yield grade is an estimate of boneless, closely 
trimmed retail cuts, with a yield grade 1 having more retail yield 
than a yield grade 5, which is much less lean with more fat. 
Culture methods. Samples of feces and TRM cells were 
cultured to assess for shedding and intestinal colonization, re- 
spectively. Fecal samples were cultured for E. coli 0157:H7 by 
procedures that have been previously described (57). For each 
fecal sample, a 10-g aliquot was added to 90 ml of gram-negative 
broth containing vancomycin at 8 ~ g l m l ,  cefixime at 50 nglml, 
and cefsulodin at 10 pglml and incubated at 37OC for 6 h. After 
incubation, 1 ml of culture broth was removed and subjected to 
E. coli 0157 immunomagnetic separation (Dynal, Lake Success, 
N.Y.). Twenty microliters of the final immunomagnetic separation 
suspension was plated on sorbitol MacConkey agar containing 
cefixime (0.05 pglml) and tellurite (2.5 pglml). Three isolated, 
non-sorbitol-fermenting colonies per plate were picked and reiso- 
lated on plates containing sorbitol MacConkey agar containing 
FIGURE 1. Use of a sterile glass micro- - -1 
scope slide to obtain tenninal rectum mu- 
cosal (TRM) cells from a 2.5-cm-wide cir- 
cumferential band extending from 3.0 to 
5.5 cm proximal to the rectoanal junction. 
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cefixime (0.05 pglml) and tellurite (2.5 pg/ml) to ensure the pu- 
rity of isolates. One well-isolated nonsorbitol-fermenting colony 
was picked from each subculture and inoculated onto Fluorocult 
(EM Science, Gibbstown, N.J.) and MacConkey agars and into 
MacConkey broth and E. coli broth, the last to which 4-methyl- 
umbelliferyl-P-D-glucuronide had been added. Isolates that fer- 
mented lactose but were negative for P-glucuronidase activity 
both by Fluorocult and E. coli broth culture were subjected to 
latex agglutination tests for E. coli 0157 and H7 antigens (Remel, 
Lenexa, Kans.). Isolates that agglutinated anti-0157-coated latex 
beads, regardless of H7 agglutination results, were tested further 
by multiplex PCR. The multiplex PCR was a five-primer-pair as- 
say that has been previously described (50) but detects the pres- 
ence of rfbE0157:H7 (46), fliCh7 (18), stxl (45), stx2 (477, and 
eaeo157 (19). The rfbE0157:H7 gene encodes an enzyme required 
for the synthesis of the E. coli 0157 antigen (4, 46); the eaeo15, 
gene encodes intimin of E. coli 0157:H7 origin and is relatively 
0 serogroup-specific (19); and the fliCh7 gene encodes the struc- 
tural protein of the H7 flagellum (18). Confirmation of an isolate 
being E. coli 0157:H7 was dependent on a positive reaction for 
both rfbE0157:H7 and fliCh7 and at least one of the virulence factor 
genes (i.e., stxl, stx2, or eae0157). Use of these criteria allows the 
detection of E. coli 0 1  57:H7 strains that have lost stx or eaeo157 
genes and also circumvents the ambiguity associated with the non- 
motile designation (1 8). 
TRM cell suspensions in transport media were cultured by 
enrichment by adding 5 ml of suspension to 45 ml of gram-neg- 
ative broth containing vancomycin at 8 pglml, cefixime at 50 ngl 
ml, and cefsulodin at 10 pg/ml and incubating for 6 h at 37°C. 
Procedures to isolate and identify E. coli 0157:H7 from the TRM 
cell enrichment' cultures were identical to those described above 
for the fecal cultures. Fecal and TRM isolates that, collectively, 
were sorbitol nonfermenting, lactose fermenting, negative for P- 
glucuronidase activity, and positive for the 0157 antigen were 
tested in the five-primer-pair multiplex PCR assay, as described 
above. As noted above, detection of genes for 0157, H7, and at 
least one other target in the assay was considered confirmation of 
an isolate as E. coli 0157:H7. 
Indirect ELISA to detect serum antibodies to type 111 se- 
creted proteins. Serum antibody titers to E. coli 0157:H7 anti- 
gens, including EspA, EspB, translocated intimin receptor (Tir), 
intimin, and 0157 lipopolysaccharide (LPS), were determined on 
two steers from each of the 18 pens in the A and B treatment 
groups. The indirect ELISA was conducted by a modification of 
procedures previously described (34). E. coli BL21 ADE3 lyso- 
gens transformed with recombinant pET28a His-tag expression 
vectors (Novagen, EMD Biosciences-Merck, San Diego, Calif.) 
containing cloned tir-cesT, eae, espA, or espB genes were provid- 
ed by Dr. B. Brett Finlay. Purified His-tagged proteins were ob- 
tained from these strains by standard procedures (Novagen His- 
Bind Kit). The region of the eae gene cloned into the recombinant 
intimin construct encoded the 280-carboxyl-terminal amino acids, 
specific for the y-intimin subtype. The source of E. coli 0157 
LPS was E. coli 0157:H7 strain 86-24, obtained by phenol-water 
extraction and purified by standard methods (24). Individual wells 
of microtiter plates were coated with 100 p1 of EspA (150 ng), 
EspB (250 ng), Tir (100 ng), intimin (200 ng), or 0157 LPS (200 
ng) in a 0.1 M carbonate solution and incubated overnight at 4OC. 
Wells were washed four times, blocked overnight at 4°C with 
60°C heat-treated 1 % bovine serum albumin in 0.1 M carbonate 
solution, and washed as described above. Twofold serial dilutions 
of sera from 1:100 to 1:204,800 were made, and 100 p1 of each 
dilution was added to wells in duplicate. Plates were incubated 
for 3 h at 37°C and washed and blocked as described above. One 
hundred microliters of a 1:5,000 dilution of affinity-purified, 
horseradish peroxidase-conjugated, H +L goat anti-bovine IgG 
(Jackson ImmunoResearch Laboratories, West Grove, Pa.) was 
added to each well, and then plates were incubated for 1 h at 37°C 
and washed four times. One hundred microliters of orthophenyl- 
enediamine (1 mglml) was added, and plates were incubated at 
room temperature for 20 min. Fifty microliters of 3 M o-phos- 
phoric acid was added, and A492 was measured. The antibody titer 
was the highest dilution having an absorbance (mean minus 1 
SEM) greater than the negative control (mean plus 1 SEM), the 
latter of which included all reagents except primary serum. 
Statistical analyses. The effect of vaccine treatment on the 
probability to detect E. coli 0157:H7 from feces was tested by 
multivariable modeling of the number of culture-positive individ- 
uals per number of individuals within the pen with a logit link, 
binomial distribution, generalized estimation equation (GEE) 
model (Proc GENMOD, SAS Institute, Cary, N.C.). A first-order 
autoregressive correlation structure was defined to account for 
clustering by repeated measures of pens over time. The models 
were fashioned by a manual forward selection process with the 
opportunity for subsequent backward elimination so that variables 
in the final model were significant at a 5 0.05 with the score 
statistic for type 3 GEE analysis. Fixed effects tested in the model 
were vaccine treatment, dietary treatment, and test period. Two- 
way interactions between these variables were also tested. Model 
fit was assessed by evaluating the deviance parameter. 
The effect of vaccine treatment on the probability of colo- 
nization was tested by multivariable modeling of the number of 
TRM culture-positive individuals per number of individuals with- 
in the pen with a logit link function, binomial distribution, GEE 
model (Proc GENMOD, SAS). Compound symmetry was the de- 
fined correlation structure to account for the clustering of animals 
within a pen. The model was fashioned by a manual forward 
selection process with subsequent backward elimination so that 
variables in the model were significant at a I 0.05 by the score 
statistic for type 3 GEE analysis. Fixed effects tested in the model 
were vaccine and dietary treatment. Model fit was assessed by 
evaluating the deviance parameter. 
Least-squared means of the parameter estimates from logistic 
regression models were used to estimate model-adjusted proba- 
bilities of E. coli 0157:H7 outcomes for the levels of each class 
variable in the model. Relative risk values for vaccine treatment 
were calculated from the model-adjusted probabilities, and vac- 
cine efficacy was calculated as 1 minus relative risk. 
Serum antibody titers were log2 transformed prior to statis- 
tical analysis. The effect of vaccination on the magnitude of titer 
change from prevaccination until either (i) 14 days after the vac- 
cine regimen was completed or (ii) the day of harvest (56 days 
after the vaccine regimen was completed) was tested in a gener- 
alized linear mixed model (Proc MIXED, SAS) with pen as a 
random effect. The effect of vaccination on the probability of a 
fourfold (2 log2) or greater titer change from prevaccination until 
either (i) 14 days after the vaccine regimen was completed or (ii) 
the day of harvest was tested in a logit link function, binomial 
distribution, GEE model (Proc GENMOD, SAS), accounting for 
a compound symmetry correlation structure by pen. Statistical sig- 
nificance was at a I 0.05. Model fit was assessed by evaluating 
the deviance parameter. 
The effect of vaccination on feedlot performance outcomes 
of average daily gain, daily DM intake, and feed efficiency was 
evaluated in generalized linear mixed models (Proc MIXED, 
SAS). Pen was the experimental unit. Fixed effects were vacci- 
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FIGURE 2. Mean probability that cattle will shed E. coli 0157: 
H7 in feces at each of the posttreatment test periods for vacci- 
nated (solid diamond) and placebo-treated (hollow square) pens 
of cattle. The greatest probability of shedding in either treatment 
group occurred simultaneously with a 6.4-cm rain event on 21 
September, 1 day prior to harvest. Error bars represent 1 stan- 
dard error. 
nation and dietary treatment. Treatment means were considered 
significantly different at a i 0.05. 
The effect of vaccination on individual carcass characteristics 
of hot carcass weight, 12th-rib fat thickness, marbling score, and 
yield grade was evaluated in a generalized linear mixed model 
(Proc MIXED, SAS). Fixed effects were vaccination and dietary 
treatment. Treatment means were considered significantly different 
at a 5 0.05. Pen was included in the model as a random effect. 
Observations from cattle that were held 1 additional day before 
harvest were excluded from carcass data analysis. 
RESULTS 
Five steers were removed (n = 2 vaccinated, n = 3 
placebo) from the trial prior to the first test period sampling 
because of receiving the wrong vaccine (n = 3) or factors 
unrelated to the study (n = 2). All steers on trial were fed 
for 126 days and were sent to harvest on 21 September 
2004; however, a scheduling error at the abattoir prevented 
all from being harvested on the same day. Two hundred 
forty-seven steers were harvested on 22 September, and the 
remaining 36 were harvested on 23 September. All cattle 
harvested on the second day were vaccinated steers. TRM 
cell samples were not collected from two vaccinated steers 
harvested on 22 September, most likely because the iden- 
tification tags were lost. 
Fecal cultures. E. coli 0157:H7 was recovered from 
90 (6.4%) of 1,410 fecal samples. During the pretreatment 
sampling period, the mean pen-level prevalences of steers 
shedding E. coli 0157:H7 within the vaccinated and pla- 
cebo-treated pens were 6.3 and 1.4%, respectively (P = 
0.07). The probability that steers would shed E. coli 0157: 
H7 at the start of the trial was not significantly different by 
dietary treatment assignments (P = 0.92). E. coli 0157:H7 
& 
I - I I I I i 
0 0.1 0.2 0.3 0.4 0.5 0.6 
Fecal prevalence 
FIGURE 3. Correlation between prevalence of E. coli 0157 in 
feces and terminal rectum mucosa 1 day later from pens of pla- 
cebo-treated cattle. Prevalence of the two measures was positively 
correlated (r = 0.60, P = 0.008). The solid line represents the 
least-squares linear regression. 
was cultured from 79 of 1,127 fecal samples obtained dur- 
ing the postvaccination test periods. The mean pen-level 
prevalence of E. coli 0157:H7 isolated from feces was 4.6, 
5.0, 6.0, and 12.4%, respectively, for test periods corre- 
sponding to 14, 28, 42, and 56 days after completion of the 
three-dose regimen. A total of 36 (6.4%) of 564 samples 
were from vaccinated steers, and 43 (7.5%) of 563 were 
from placebo-treated steers. At each of the three posttreat- 
ment test periods prior to the last sampling date, the post- 
treatment prevalence of fecal shedding was lower among 
vaccinated cattle than placebo-treated cattle (P = 0.07). 
However, this picture changed during the last sampling pe- 
riod in the feedyard (Fig. 2). At the last test period, the 
prevalence of fecal shedding among vaccinated cattle was 
greater than during previous periods. A major rain event 
(6.4 cm of rain) occurred in the early hours of 21 Septem- 
ber prior to testing. On the day prior to sampling (20 Sep- 
tember), the pen surface condition score of every pen on 
study was recorded as dry and dusty, but prior to sampling 
cattle on 21 September, the pen surface conditions for all 
pens were recorded as extremely wet and muddy. 
When all four posttreatment periods were considered 
in the analysis, neither vaccination treatment (odds ratio 
[OR] = 0.81, P = 0.57), diet (P = 0.41), nor test week (P 
= 0.58) significantly explained the probability that cattle 
would shed E. coli 0157:H7 in the feces. 
Culture of TRM cells. Samples of TRM cells were 
collected from 281 steers at harvest. A total of 1 (0.71%) 
of 140 TRM cell samples collected from vaccinated cattle 
tested positive for E. coli 0157:H7, whereas 38 (27.0%) of 
14 1 TRM cell samples collected from placebo-treated cattle 
tested positive. Within placebo-treated pens, the prevalence 
of fecal shedding prior to loading cattle for harvest on 21 
September correlated with the prevalence of colonization at 
harvest 1 day later (r = 0.60, P < 0.008; Fig. 3). 
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TABLE 2. Multivariable logistic regression model of the proba- 
bility of culturing E. coli 0157:H7 from samples of terminal rec- 
tum mucosal cells from steers vaccinated against E. coli 0157: 
H7 or treated with placebo and fed in a research feedloFb 
95% 
Parmeter Odds confidence 
Variable Unit estimate ratio interval P value 
Intercept -0.914 0.03 
Vaccination Vaccine -4.2881 0.014 0.002 0.085 <0.0001 
Placebo 0 1 .OO Referent 
Diet 10DG -1.4544 0.23 0.03 1.57 0.04 
20DG - 1.4994 0.22 0.07 0.75 
30DG -2.'192 0.1 1 0.02 0.70 
40DG 0.945 2.57 0.92 7.17 
50DG 1.3413 3.82 0.98 14.99 
OODG 0 1 .OO Referent 
a IODG, 10% distillers' grains in finishing diet; 20DG, 20% dis- 
tillers' grains in finishing diet; 30DG, 30% distillers' grains in 
finishing diet; 40DG, 40% distillers' grains in finishing diet; 
50DG, 50% distillers' grains in finishing diet; OODG, no distill- 
ers' grains in finishing diet. 
Deviance parameter divided by degrees of freedom = 0.78, in- 
dicating slight underdispersion in the model. 
The factors explaining the probability that TRM cell 
samples from steers would test culture positive for E. coli 
0157:H7 in the multivariable logistic regression model (Ta- 
ble 2) were vaccination treatment (OR = 0.014, P < 
0.0001) and diet (P = 0.04). There was no significant in- 
teraction between diet and vaccination treatment, vaccina- 
tion and test period, or diet and test period. The model- 
adjusted probability of E. coli 0157:H7 colonization in the 
terminal rectum was 0.003 and 0.199 for vaccinated and 
a : 1 3 1 ~  
EspA EspB 
rn 
placebo-treated steers, respectively. Vaccine efficacy for 
preventing colonization was 98.3%. 
Serology. At the time of the first vaccination, all cattle 
in the study were seropositive for each of the E. coli 0157: 
H7 antigens tested, but the titers were not significantly dif- 
ferent between the two treatment groups. From prevaccin- 
ation to 14 days after completion of treatment regimen (Fig. 
4), the magnitudes of the seroresponse (change in log2 titer 
values) of vaccinated cattle were 0.89 and 3.03 to Tir (P 
= 0.04) and 0157 LPS (P < 0.0001), respectively. Simi- 
larly, during the same period, vaccinated cattle had signif- 
icantly greater probabilities for a fourfold or greater sero- 
response to Tir (OR = 2.7, P = 0.04) and 0157 LPS (OR 
= 8.0, P < 0.0001) than placebo-treated cattle. From pre- 
vaccination to harvest (Fig. 4), vaccinated cattle had a sig- 
nificantly greater magnitude of seroresponse (P = 0.0008) 
and greater probability of a fourfold or greater seroresponse 
(OR = 4.9, P = 0.003) to 0157 LPS. However, neither the 
magnitude of seroresponse to Tir (P = 0.23) nor the prob- 
ability of a seroresponse (P = 0.46) was significantly dif- 
ferent from prevaccination to harvest. From prevaccination 
to 14 days after treatment regimen, the magnitudes of the 
seroresponse of vaccinated cattle were 0.44, 0.58, and 0.22 
greater than those of placebo-treated cattle to EspA (P = 
0.30), EspB (P = 0.10), and intimin (P = 0.57), respec- 
tively. Similarly, the probabilities of a fourfold or greater 
seroresponse to EspA (OR = 1.15, P = 0.81), EspB (OR 
= 2.07, P = 0.17), and intimin (OR = 0.63, P = 0.46) in 
vaccinated cattle were not significant compared with pla- 
cebo-treated cattle. 
Feedlot performance and carcass characteristics. 
There was no interaction between diet and vaccination 
treatment for feedlot performance or carcass characteristic 
I Intimin I Tir 
Antigen 
Vaccine H Placebo 
cO : l 3 l ~  
LPS 
FIGURE 4. Geometric mean antibody ti- 
ters against specijic antigens measured 
from serum collected from a subset of vac- 
cinated and placebo-treated cattle at var- 
ious days in the feedyard. Feedlot days 28, 
84, and 126 correspond to the day of jrst  
treatment, 14 days after completing the 
treatment regimen, and the last day in the 
feedyard (56 days after completing the 
treatment regimen), respectively. 
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outcomes. Feedlot performance, adjusted for dietary treat- 
ment, was not significantly different among vaccinated and 
placebo-treated pens of steers. Initial trial BW averaged 352 
kg ( P  = 0.89). Final live BW was not different ( P  = 0.92) 
and averaged 584 kg for vaccinated and placebo-treated 
steers. Daily DM intake averaged 11.00 kg for vaccinated 
cattle and 11.15 kg for placebo-treated cattle (P  = 0.24). 
Average daily gains were 1.84 and 1.85 kg (P = 0.87) for 
vaccinated and placebo-treated pens of steers, respectively. 
Feed efficiency averaged 0.167 for vaccinated pens of 
steers and 0.165 (P  = 0.45) for placebo-treated pens of 
steers. 
Carcass characteristics of hot carcass weight, 12th-rib 
fat thickness, and USDA yield grade for vaccinated and 
placebo-treated steers, adjusting for diet, were not signifi- 
cantly different for vaccinated or placebo-treated steers. Hot 
carcass weight averaged 366 kg for vaccinated cattle and 
369 kg for placebo-treated cattle (P  = 0.32). Fat thickness 
averaged 1.26 cm for vaccinated cattle and 1.22 cm for 
placebo-treated cattle ( P  = 0.40). Yield grade averaged 
2.57 for vaccinated cattle and 2.69 for placebo-treated cattle 
(P = 0.16). Paradoxically, the USDA marbling score did 
differ between treatment groups. The marbling score aver- 
aged 405 for vaccinated cattle and 423 for placebo-treated 
cattle ( P  = 0.05). 
DISCUSSION 
The most important finding of this study was that vac- 
cinated cattle were less likely to be colonized at the TRM. 
We assessed vaccine efficacy by determining the extent to 
which colonization of the TRM was prevented, because this 
is an important site of colonization (41, 42). To our knowl- 
edge, this is the first report to evaluate a preharvest inter- 
vention for the control of E. coli 0157:H7 with coloniza- 
tion of TRM as the outcome variable. This finding is con- 
sistent with the hypothesized mode of action of this vac- 
cine. It was unfortunate, but unavoidable, that problems at 
the plant required a delay in harvesting TRM cells from 
some cattle. However, the data provide no evidence of bias 
resulting from this delay. 
Vaccines designed to protect humans and animals 
against E. coli and other enteric infections are, in general, 
aimed at preventing intestinal colonization and often re- 
quire the ability to induce a significant mucosal immune 
response to be efficacious (33, 43). The primary targets of 
E. coli vaccines that attempt to prevent intestinal coloni- 
zation are bacterial adherence factors (61). For E. coli 
0157:H7, proof-of-concept studies have shown that anti- 
bodies directed against intimin, an adherence factor known 
to play a significant role in colonization in different species, 
including adult cattle (9, 37), reduce bacterial adherence to 
epithelial cells, both in vitro and in vivo (12, 20). LEE- 
encoded type I11 secreted proteins, including Tir, are also 
important for colonization of the bovine intestine (42), and 
Tir is thought to mediate its effect on colonization primarily 
by binding to the C-terminal region of intimin (64). Further, 
antibodies to EspA, another type I11 secreted protein in- 
volved in initial adherence and attaching-effacing lesion de- 
velopment, block development of these lesions. (30). 
In a previous study, a vaccine containing type I11 se- 
creted proteins effectively reduced the probability that feed- 
lot steers would test positive for E. coli 0157:H7 in the 
feies (50). In the present study, however, we were unable 
to observe significant differences between vaccinated and 
placebo-treated cattle in the probability of detecting E. coli 
0 157:H7 from feces. However, the overall probability of 
detecting E. coli 0157:H7 among placebo-treated cattle in 
this study was very low compared with our previous ob- 
servations of untreated cattle in research and commercial 
feedyards (27, 50, 57). The present study was designed with 
sufficient power to detect differences similar to those ob- 
served in an earlier study (50) in the same feedlot during 
a similar time of year; however, the probability of detecting 
E. coli 0157:H7 in the feces of placebo-treated cattle 
(21.3%) in that study was greater than what was observed 
in the present study (7.5%). Other researchers who inves- 
tigated a vaccine containing type I11 secreted proteins in a 
large-scale commercial feedyard study did not find signif- 
icant differences in the fecal shedding of E. coli 0157:H7 
between vaccinates and nonvaccinates, possibly because of 
low overall shedding prevalence, large within-pen variabil- 
ity, and a different vaccine formulation (viz. formalin-treat- 
ed antigen) (63). 
Regardless of the overall low probability of cattle shed- 
ding E. coli 0157:H7 in feces throughout the study, a 
weather event may have had the greatest impact on our 
ability to observe treatment differences in fecal shedding. 
Immediately prior to harvest, vaccinated and placebo-treat- 
ed cattle were suddenly exposed to wet and muddy pen 
conditions, which have been shown to provide a greater 
opportunity for fecal-oral transmission of E. coli 0157:H7 
(57, 58). We suspect the organisms we isolated from the 
feces were simply passing through the intestinal tract, and 
the rain event serendipitously provided an opportunity to 
witness the colonization outcome following the sudden oral 
challenge. In the feedlot, prior to loading, cattle from both 
treatment groups shed organisms in feces at the highest rate 
of the study; however, at harvest, vaccinated cattle were 
significantly less likely to be detected as colonized than 
placebo-treated controls. This finding is consistent with the 
proposed mechanism of action of this vaccine product (50), 
previous longitudinal studies showing a wide variation in 
shedding prevalence over time (27, 50), and the relationship 
between weather-related factors and the feedlot occurrence 
of E. coli 0157:H7 (58). 
The vaccine used in this study was prepared from cul- 
ture supernatant, and the primary intended antigens were 
type 111 secreted proteins, although 0157 LPS was also 
present. Although we did not attempt to measure antibodies 
to type I11 secreted proteins in intestinal secretions, we did 
determine that vaccination induced a significant IgG sero- 
response to Tir and 0 157 LPS. IgGl plays a highly signif- 
icant role in mucosal immunity in cattle and other rumi- 
nants, in addition to secretory IgA; in cattle, IgGl is ac- 
tively secreted across epithelial surfaces, including the in- 
testinal mucosa (5). In cattle, subcutaneous immunization 
induces significant IgG1, IgM, and IgG2 seroresponses 
(51). In adult humans, immunization with an investigational 
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vaccine consisting of E. coli 0157 0-specific polysaccha- 
ride-Pseudomonas aeruginosa recombinant exoprotein A 
conjugate induced high titers of serum bactericidal activity 
that roughly correlated with the serum IgG and IgM anti- 
body levels (28). 
We speculate that, in vaccinated cattle, antibodies to 
type I11 secreted proteins and possibly other bacterial com- 
ponents (e.g., 0157 LPS) were transported into the intes- 
tinal lumen and blocked colonization. We further speculate 
that colonization was prevented or reduced by interference 
with attaching-effacing lesion formation and possibly other 
adherence mechanisms. In two previous studies, we found 
that this vaccine product reduced the probability of E. coli 
0157:H7 fecal shedding in cattle (49, 50). Antibodies to 
0157 LPS are also known to mediate bactericidal activity 
against E. coli 0 157:H7 through complement-mediated ly- 
sis and could play a role in mucosal immunity by killing 
bacteria in the intestinal lumen and on the surfaces of ep- 
ithelial cells (28, 40). An additional role for anti-0157 an- 
tibodies could be to enhance the opsonization of bacteria. 
However, a previous study had reported that serum anti- 
body titers to 0157 LPS were not correlated with reduced 
fecal shedding or protection against repeat challenge in cat- 
tle (25). 
The probability of detecting E. coli 0 1  57:H7 in TRM 
cells from cattle was different for cattle fed different levels 
of DG. In a previous study, dietary substitution of dry- 
rolled corn with corn bran and wet corn gluten feed did not 
affect the probability that cattle would shed E. coli 0157: 
H7 in the feces (36). However, more recently, we found 
that the corn component of the diet affected the probability 
that cattle would test positive for E. coli 0157:H7 in feces 
(49). A variety of diets and dietary components have been 
associated with the probability that cattle and sheep would 
shed E. coli 0157:H7 in feces (14, 15, 29, 54). However, 
the mechanisms by which diet or diet components might 
affect E. coli 0157:H7 fecal shedding patterns are unclear. 
Feedlot performance and carcass characteristics did not 
differ between vaccinated and placebo-treated cattle with 
the exception of marbling score. It is unclear why, in this 
study, marbling was decreased among vaccinated cattle 
without the observation of other carcass or performance 
effects. Further, in two other studies with larger numbers 
of cattle, we did not observe an effect of vaccination on 
marbling score (49, 56). Therefore, we believe the obser- 
vation in the present study is a spurious result from ex- 
amining multiple carcass outcomes. 
Results from this study suggest that this vaccine prod- 
uct effectively reduces the probability that cattle will be- 
come colonized by E. coli 0157:H7 in TRM cells under 
conditions of natural exposure, a first step in its evaluation 
as an effective intervention for food and environmental 
safety. 
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